MedPath

Review and Comparison of sedative effect in using of chloral hydrate and midazolam on children under voiding cystourethrogram

Phase 2
Conditions
Vesico uretro reflux.
Congenital vesico-uretero-renal reflux
Q62.7 , N
Registration Number
IRCT2016041927494N1
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Entrance general conditions to Study: children from 2 - 12 years old both male & female? Children with indication VCUG? children with ASA 1 or 2? obtaining the informed consent from parents or guardian of children To participate in the study

Exclusion general conditions from Study: History of systemic chronic diseases such as Renal failure, Respiratory disease and etc? history of narcotic abuse? history sensitivity to midazolam or chloral hydrate? history chronic psychiatric disease including: ADHA, Anxiety, Depression, psychos and Metal retardation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sedation. Timepoint: On time with study. Method of measurement: Visit & question from parents.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath